Horng-Chi Huang

Title: Horng-Chi Huang: Innovator in Pharmaceutical Chemistry

Introduction

Horng-Chi Huang is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating inflammation. With a total of 2 patents, his work has the potential to impact the treatment of various inflammation-related disorders.

Latest Patents

Huang's latest patents focus on a class of substituted spiro compounds designed for the treatment of inflammation. These compounds are defined by specific chemical formulas, where n can be 0, 1, or 2, and R³ can be methylsulfonyl or sulfamyl. Additionally, R⁸ can be selected from a wide range of chemical groups, including hydrido, fluoro, chloro, bromo, and various alkyl and functional groups. These innovations represent a promising avenue for pharmaceutical development.

Career Highlights

Huang is associated with G.D. Searle & Company, where he has been instrumental in advancing research in pharmaceutical compounds. His expertise in chemistry and innovation has led to the creation of valuable therapeutic options for patients suffering from inflammation.

Collaborations

Throughout his career, Huang has collaborated with esteemed colleagues, including David B. Reitz and Robert E. Manning. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Horng-Chi Huang's contributions to pharmaceutical chemistry, particularly in the area of inflammation treatment, highlight his role as an innovative inventor. His work continues to pave the way for advancements in medical treatments.